Mon.Jul 15, 2024

article thumbnail

Amgen, BMS and Merck have the most exposure as Big Pharma eyes $183B patent cliff: analyst

Fierce Pharma

While patent cliffs are looming for many of biopharma’s top-selling products, the industry has enormous capacity to respond as “conditions for M&A are favorable,” according to a research note f | While patent cliffs loom for many of biopharma’s top-selling products, the industry has enormous capacity to respond as “conditions for M&A are favorable,” according to a July 11 research note from Morgan Stanley.

Pharma 355
article thumbnail

Is Medical Equipment Sales a Growing Field?

David Bagga

Medical Device Sales Academy Is Medical Equipment Sales a Growing Field? Healthcare and medicine are rapidly developing sectors. In the upcoming years, careers in this field will boom. People interested in this field and looking for jobs need the necessary education and skills. Many experts have predicted that the medical sector, including sales, will continue […] The post Is Medical Equipment Sales a Growing Field?

Medical 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA proposes cell and gene therapy site tours to help regulators learn from industry

Fierce Pharma

It's no secret that cell and gene therapies have faced manufacturing hurdles as the advanced medicines have become increasingly popular in recent years. | It's no secret that cell and gene therapies have faced manufacturing hurdles as the advanced medicines have become increasingly popular in recent years. Now, the FDA is proposing to work directly with industry through a series of facility tours that could enable both sides to learn something from each other.

FDA 319
article thumbnail

Digital Health’s Funding Rebound Is Going Well, Market Research Shows

MedCity News

The digital health fundraising market seems to be truly normalizing following the highs and lows of the pandemic, according to market research. During the first half of this year, U.S. digital health startups raked in $5.7 billion across 266 deals. The post Digital Health’s Funding Rebound Is Going Well, Market Research Shows appeared first on MedCity News.

Marketing 124
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

J&J’s CAR-T partner Legend Biotech reportedly receives buyout offer

Fierce Pharma

CAR-T specialist Legend Biotech has reportedly received a takeover bid and has tapped Centerview Partners as a financial adviser to evaluate its options, StreetInsider

288
288
article thumbnail

Report: Cost Reduction Is Less of a Priority for Health CFOs Compared to Past Years

MedCity News

Cost reduction is no longer a top priority for healthcare finance leaders, a new Deloitte survey found. In past years, cost reduction was among the top three priorities. The post Report: Cost Reduction Is Less of a Priority for Health CFOs Compared to Past Years appeared first on MedCity News.

More Trending

article thumbnail

Positive Data in Pancreatic Cancer Pave Way for Pivotal Test of Revolution Medicines Drug

MedCity News

Revolution Medicines drug RMC-6236 increased progression-free survival in patients with advanced cases of pancreatic ductal adenocarcinoma. With these results, the biotech is preparing for a Phase 3 clinical trial in this indication, the most common type of pancreatic cancer. The post Positive Data in Pancreatic Cancer Pave Way for Pivotal Test of Revolution Medicines Drug appeared first on MedCity News.

Medicine 106
article thumbnail

Vertex sues US for right to provide fertility assistance program to gene therapy patients

Fierce Pharma

To receive Vertex and CRISPR Therapeutics’ $2.2 million gene therapy Casgevy for sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), patients must first undergo chemotherapy | Vertex has filed a lawsuit in federal court in Washington, D.C. against the U.S. Department of Health and Human Services (HHS) seeking to overturn the “erroneous legal positions” of the agency’s Office of the Inspector General (OIG).

Patients 171
article thumbnail

AstraZeneca’s Tagrisso gains approval in Canada for NSCLC

Pharmaceutical Technology

AstraZeneca has obtained Health Canada’s Notice of Compliance (NOC) for Tagrisso (osimertinib) to treat NSCLC.

114
114
article thumbnail

Treating Rheumatoid Arthritis Patients With Biosimilars Versus Leflunomide: An Economic Evaluation

Pharmaceutical Commerce

A study explores the cost-effectiveness of combining methotrexate with various drugs as a way to combat failed methotrexate monotherapy.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Call goes out for simpler clinical trial regulation in UK

pharmaphorum

Framework governing early-stage clinical trials in the UK is stifling research and needs to be simplified, says BJCP paper

article thumbnail

5 Strategies to Better Connect Patients with Substance Use Treatment 

MedCity News

How marketing can help patients find a treatment center that can address their long-term care needs The post 5 Strategies to Better Connect Patients with Substance Use Treatment appeared first on MedCity News.

article thumbnail

EMA’s PRAC Offers Recommendations for Glucagon-like Peptide-1 Receptor Agonists and Glatiramer Acetate

PharmaTech

PRAC is recommending that patients who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs) consider the risk of delayed gastric emptying before undergoing surgery with general anesthesia or deep sedation.

article thumbnail

How to Perform an SEO Competitor Analysis for Healthcare

Healthcare Success

The battle for the top position on Google search engine page results (SERPs) gets more difficult each year. As a result, you'll need to gain a deeper understanding of your primary and secondary competitors before you can start any new website build, redesign, restructuring project, or digital marketing campaign. You’ll need a competitor analysis for SEO.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

article thumbnail

Trial finds over-the-counter nasal sprays could reduce RTIs and antibiotic use

PharmaTimes

Affecting parts of the body involving breathing, RTIs impact one in five people in England

96
article thumbnail

Germany inches closer to confidential pricing for drugs

pharmaphorum

Germany inches closer to confidential pricing for patented medicines, with passage of Medical Research Act

Medicine 105
article thumbnail

Pharma’s attitudes on AI revealed

European Pharmaceutical Review

A survey by Elsevier has shown that researchers in the pharmaceutical and life sciences sectors consider artificial intelligence (AI) to be positive, with respondents stating that the future impact of the technology will be “transformative or significant.” The data showed that over 38 percent of those who engaged in the survey have used it professionally.

Ethics 64
article thumbnail

Lantheus Acquires Meilleur Technologies, PET Imaging Agent

PharmaTech

The acquisition provides Lantheus with worldwide exclusive rights to ß amyloid PET imaging agent, NAV-4694, for its Alzheimer’s disease diagnostic and treatment portfolio.

64
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Building Safer Healthcare Environments through Human Factors and Ergonomics

MedCity News

Human Factors and Ergonomics (HF/E) play a major role, acting as a bridge between the human element and the healthcare system. Creating a work environment where human potential flourishes, and where technology serves as a seamless extension of our ability to care. The post Building Safer Healthcare Environments through Human Factors and Ergonomics appeared first on MedCity News.

article thumbnail

Lexeo therapy gives hope to Friedreich's ataxia patients

pharmaphorum

An experimental gene therapy developed by Lexeo Therapeutics has shown early promise in treating one of the most serious complications of rare neurodegenerative disorder Friedreich's ataxia (FA).In a phase 1/2 SUNRISE-FA trial, the LX2006 therapy showed a reduction in cardiomyopathy – the most common cause of death in FA – in an initial group of patients with enlarged hearts at the start of the trial.

article thumbnail

NIHR and Diabetes UK invest nearly £3m to prevent and treat diabetes distress

PharmaTimes

Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress

87
article thumbnail

Investors take issue with Taisho Pharma’s buyout price

pharmaphorum

Two investment funds have decided to contest Taisho Pharma’s recently announced management buyout plan in court

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Pharma Pulse 7/15/24: What to Know About Medication and Summer Travel, The Future of Periodontal Treatment & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

Exploring Melbourne’s booming life sciences sector

Pharmaceutical Technology

Australia is fast becoming the place to be for innovative life sciences companies, as proved by Melbourne’s latest FDI wins from the likes of BioNTech and Moderna.

59
article thumbnail

Is a better CAR-T cell therapy option on the horizon?

PharmaVoice

In vivo CAR-T cell technology has the potential to solve some major issues in the field and could enter the clinic this year.

69
article thumbnail

2024 ISPE Annual Meeting & Expo: Oct. 13-16, 2024

PharmaTech

The annual event covers supply chain, operations, facilities, and regulatory affairs, the role of data science including model-informed drug development (MIDD), and technology in shaping the future of product development, production systems, and quality assurance.

52
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

From Clicker to Healer: A Rep's Redemption

Contrarian Sales Techniques

Ava waltzed into Dr. Khan's office like a human PowerPoint presentation, clicker poised like a lightsaber. Numbers danced behind her eyelids - trial results, market share, the whole sales rep arsenal. Her spiel was flawless, a symphony of medical jargon and clinical data. Dr. Khan, however, remained stubbornly unmoved. He'd seen his fair share of these med reps, all charm and brochure, more glitter than stethoscope.

Doctors 52
article thumbnail

Pelletization: Revolutionizing Drug Formulation and Delivery

PharmaTech

Pelletization, a popular oral drug delivery method in pharmaceuticals and nutraceuticals, offers numerous benefits. This article delves into the critical parameters for formulation development and technological consideration in pelletization, elucidating its significance in advancing pharmaceutical solutions.

article thumbnail

How to Successfully Market Your GLP-1 Program: Strategies for Standing Out

LEVO Health

The GLP-1 market is rapidly expanding, driven by the increasing prevalence of obesity and diabetes and the efficacy of GLP-1 medications in managing these conditions. In 2021, the GLP-1 market was valued at $16.53 billion and is projected to reach $24.10 billion by 2027. This growth presents a significant opportunity for healthcare organizations and businesses, but it also means the market is becoming increasingly saturated.

article thumbnail

AAPS 2024 PHARMSCI 360: October 20-23, 2024

PharmaTech

The event covers Discovery and Basic Research, Preclinical, Clinical and Translational Sciences, Bioanalytics, Manufacturing and Analytical Characterization, Formulation and Delivery, and Career Development.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.